Article Text

Download PDFPDF

A2.1 Activated Neutrophils are able to Efficiently Produce Interferon-α and Retain this Capability in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
  1. Dennis Lindau1,
  2. Armin Rabsteyn1,
  3. Julie Mussard2,
  4. Matthieu Ribon2,
  5. Ina Kötter3,
  6. Gosse Adema4,
  7. Marie-Christophe Boissier2,
  8. Patrice Decker2
  1. 1University of Tübingen, Institute for Cell Biology, Department of Immunology, Tübingen, Germany
  2. 2University of Paris 13, Sorbonne Paris Cité EA4222, Li2P, Bobigny, France
  3. 3University Hospital, Internal Medicine II, Tübingen, Germany
  4. 4Nijmegen Centre for Molecular Life Sciences, Department of Tumor Immunology, Nijmegen, The Netherlands
  1. Corresponding and presenting author. patrice.decker{at}


Background and Objectives Neutrophils play a pivotal role in inflammation and contribute to systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) pathogenesis. Interferon (IFN)-α is involved in lupus development and might contribute locally to RA development. Activated plasmacytoid dendritic cells (pDC) are important producers of IFN-α but represent a minor cell population. On the other hand, neutrophils represent 50% of total blood leukocytes. Although neutrophils are not considered as IFN-α-producing cells, we have investigated whether they may produce this cytokine and the stimuli involved.

Materials and Methods PBMC and neutrophils were isolated from healthy individuals, SLE and RA patients. Mouse neutrophils were purified from the bone marrow. Cells were activated with different stimuli and IFN-α production/secretion was estimated by flow cytometry, ELISA and a bioassay. Neutrophil activation was verified by flow cytometry and ELISA. Gene expression was analysed by qRT-PCR. Neutrophil extracellular trap (NET) induction was estimated by confocal microscopy. Chromatin, a major autoantigen in SLE, was purified from calf thymus.

Results Isolated neutrophils produce IFN-α upon stimulation with Toll-like receptor (TLR) 9 and TLR7/8 agonists. IFN-α secretion by neutrophils was observed with neutrophils from both healthy donors and SLE and RA patients. Similar results were obtained with mouse neutrophils. IFN-α production by neutrophils was associated with IL-8, IL-6 and TNF-α secretion, CD66b up-regulation, ROS production and increased gene expression levels of IFN-α, IFN-β and IL-6. In low responders, PBMC sustain IFN-α secretion by neutrophils in co-cultures. Neutrophil priming is not required but GM-CSF acts synergistically with TLR9 agonists. Particularly, neutrophils respond to all types (A, B and C) of CpG-oligonucleotides. pDC are more efficient than neutrophils in producing IFN-α at the single cell level but this was largely compensated by the 200-fold excess of neutrophils in whole blood. Importantly, neutrophil-derived IFN-α was detected in response to free chromatin, a lupus autoantigen, and was associated with neutrophil extracellular trap (NET) formation (NETosis).

Conclusions Neutrophils represent an important source of IFN-α. IFN-α was detected at the mRNA and protein levels and in an active and secreted form. Both normal as well as SLE and RA neutrophils produce IFN-α in response to specific stimuli. Therefore, neutrophils represent also important targets for future therapies aiming at influencing IFN-α levels.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.